Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

NCT06385236 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

BIOLOGICAL: Dupilumab
BIOLOGICAL: Benralizumab

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]